Authors:
Casassus, P
Gibson, J
Joshua, DE
Matthews, J
Diaz, JC
Gertz, MA
Kyle, R
Leong, T
Oken, MM
Fritz, E
Ludwig, H
Corrado, C
Lastiri, F
Peest, D
Grosbois, B
Vela-Ojeda, J
Avvisati, G
Mandelli, F
Petrucci, MT
Capnist, G
Child, JA
Drayson, MT
Dunn, J
MacLennan, I
Mellstedt, H
Osterborg, A
Rodjer, S
Turesson, I
Westin, J
Bergsagel, D
Browman, GP
Shustik, C
Zee, B
Hjorth, M
Holmberg, E
Rodjer, S
Turesson, I
Westin, J
Alison, R
Clarke, M
Elphinstone, P
Evans, V
Gray, R
Hicks, C
James, S
MacKinnon, L
Peto, R
Richards, S
Wheatley, K
Blade, J
Fontanillas, M
San Miguel, J
Aitchison, R
Newland, AC
Cunningham, D
Malpas, J
Powles, RL
Montuoro, A
Jacobson, J
Salmon, S
Citation: P. Casassus et al., Interferon as therapy for multiple myeloma: an individual patient data overview of 24 randomized trials and 4012 patients, BR J HAEM, 113(4), 2001, pp. 1020-1034
Authors:
Jiang, YB
Genant, HK
Watt, I
Cobby, M
Bresnihan, B
Aitchison, R
McCabe, D
Citation: Yb. Jiang et al., A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis - Radiologic progression and correlation of Genant and Larsen scores, ARTH RHEUM, 43(5), 2000, pp. 1001-1009
Authors:
Bresnihan, B
Alvaro-Gracia, JM
Cobby, M
Doherty, M
Domljan, Z
Emery, P
Nuki, G
Pavelka, K
Rau, R
Rozman, B
Watt, I
Williams, B
Aitchison, R
McCabe, D
Musikic, P
Citation: B. Bresnihan et al., Blindedness in clinical trials of therapies for rheumatoid arthritis: comment on the article by Bresnihan et al - Reply, ARTH RHEUM, 42(8), 1999, pp. 1782-1782
Authors:
Bresnihan, B
Alvaro-Gracia, JM
Cobby, M
Doherty, M
Domljan, Z
Emery, P
Nuki, G
Pavelka, K
Rau, R
Rozman, B
Watt, I
Williams, B
Aitchison, R
McCabe, D
Musikic, P
Citation: B. Bresnihan et al., Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist, ARTH RHEUM, 41(12), 1998, pp. 2196-2204